Torthaí cuardaigh - Sandip Pravin Patel

Beachtaigh na torthaí
  1. 1
    Next generation predictive biomarkers for immune checkpoint inhibition

    Next generation predictive biomarkers for immune checkpoint inhibition de réir Yulian Khagi, Razelle Kurzrock, Sandip Pravin Patel

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1

    CEA/CD3-bispecific T cell-engaging (BiTE) antibody-mediated T lymphocyte cytotoxicity maximized by inhibition of both PD1 and PD-L1 de réir Takuya Osada, Sandip Pravin Patel, Scott A. Hammond, Koya Osada, Michael A. Morse, H. Kim Lyerly

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer

    Immune-Related Pneumonitis After Chemoradiotherapy and Subsequent Immune Checkpoint Blockade in Unresectable Stage III Non–Small-Cell Lung Cancer de réir Jarushka Naidoo, Mizuki Nishino, Sandip Pravin Patel, Bairavi Shankar, Natasha Rekhtman, Peter B. Illei, P. Camus

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations from the Center For Personalized Cancer Therapy at UC San Diego Moores Cancer Center

    Exceptional Response to Nivolumab and Stereotactic Body Radiation Therapy (SBRT) in Neuroendocrine Cervical Carcinoma with High Tumor Mutational Burden: Management Considerations f... de réir Andrew B. Sharabi, Sangwoo Shawn Kim, Shumei Kato, P. Dominick Sanders, Sandip Pravin Patel, Parag Sanghvi, Elizabeth Weihe, Razelle Kurzrock

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy

    Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy de réir Yulian Khagi, Aaron M. Goodman, Gregory A. Daniels, Sandip Pravin Patel, Assuntina G. Sacco, James M. Randall, Lyudmila Bazhenova, Razelle Kurzrock

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers

    Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers de réir Christopher J.D. Wallis, Mohit Butaney, Raj Satkunasivam, Stephen J. Freedland, Sandip Pravin Patel, Omid Hamid, Sumanta K. Pal, Zachary Klaassen

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma

    Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma de réir Maria Schwaederlé, Sandip Pravin Patel, Hatim Husain, Megumi Ikeda, Richard B. Lanman, Kimberly C. Banks, AmirAli Talasaz, Lyudmila Bazhenova, Razelle Kurzrock

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions

    Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions de réir Manuela Gago‐Dominguez, Marcos Matabuena, Carmen M. Redondo, Sandip Pravin Patel, Ángel Carracedo, Sara Miranda Ponte, Marı́a Elena Martı́nez, Jose E. Castelao

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data

    Myocarditis occurrence with cancer immunotherapy across indications in clinical trial and post-marketing data de réir Tigran Makunts, Ila M. Saunders, Isaac Cohen, Mengxing Li, Talar Moumedjian, M Issa, Keith Burkhart, Peter P. Lee, Sandip Pravin Patel, Ruben Abagyan

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

    Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers de réir Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment

    ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment de réir Na Li, Yuqi Kang, Lingling Wang, Sarah Huff, R. Tang, Hui Hui, Kriti Agrawal, Gwendolyn González, Yinsheng Wang, Sandip Pravin Patel, Tariq M. Rana

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients

    Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients de réir Maria Schwaederlé, Hatim Husain, Paul T. Fanta, David Piccioni, Santosh Kesari, Richard B. Schwab, Sandip Pravin Patel, Olivier Harismendy, Megumi Ikeda, Barbara A. Parker, Razelle Kurzrock

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy

    Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy de réir Sadakatsu Ikeda, Aaron M. Goodman, Philip R. Cohen, Taylor J. Jensen, Christopher K. Ellison, Garrett M. Frampton, Vincent A. Miller, Sandip Pravin Patel, Razelle Kurzrock

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

    Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors de réir Ben Tran, Richard D. Carvajal, Aurélien Marabelle, Sandip Pravin Patel, Patricia LoRusso, Erik Rasmussen, Gloria Juan, Vijay Upreti, Courtney Beers, Gataree Ngarmchamnanrith, Patrick Schöffski

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients

    Clinical implications of plasma circulating tumor DNA in gynecologic cancer patients de réir Lindsey M. Charo, Ramez N. Eskander, Ryosuke Okamura, Sandip Pravin Patel, Mina Nikanjam, Richard B. Lanman, David Piccioni, Shumei Kato, Michael McHale, Razelle Kurzrock

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Disparities in telemedicine during COVID‐19

    Disparities in telemedicine during COVID‐19 de réir Alexander S. Qian, Melody K. Schiaffino, Vinit Nalawade, L. Aziz, Fernanda Ventorim Pacheco, Bao Sean Nguyen, Peter Vu, Sandip Pravin Patel, Marı́a Elena Martı́nez, James D. Murphy

    Foilsithe / Cruthaithe 2022
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrine Prostate Cancer: Case Report and Review of the Literature

    A Complete Response to Combined Immunotherapy in a Patient with an ATM plus SF3B1 Mutation and a Moderate Tumor Mutational Burden with a High-Grade Treatment-Emergent Neuroendocrin... de réir Helena Ferreira Bruzzi Porto, Gabriela Carreiro Kubitschek Lopes, Hannah Barboza Vianna Bekierman, Sérgio Altino de Almeida, Felipe Andreiuolo, Evandro Lucena, Sandip Pravin Patel, Vinicius Freire, Daniel Herchenhorn

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    Revisiting Epidermal Growth Factor Receptor (<i>EGFR</i>) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies

    Revisiting Epidermal Growth Factor Receptor (<i>EGFR</i>) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Mal... de réir Shumei Kato, Ryosuke Okamura, Manvita Mareboina, Suzanna Lee, Aaron M. Goodman, Sandip Pravin Patel, Paul T. Fanta, Richard B. Schwab, Peter Vu, Victoria M. Raymond, Richard B. Lanman, Jason K. Sicklick, Scott M. Lippman, Razelle Kurzrock

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors

    Phase 1/2 study of monalizumab plus durvalumab in patients with advanced solid tumors de réir Sandip Pravin Patel, Teresa Alonso‐Gordoa, Susana Banerjee, Ding Wang, Jarushka Naidoo, Nathan Standifer, Doug Palmer, Lin‐Yang Cheng, Panagiotis Kourtesis, Maria Libera Ascierto, Mayukh Das, Jennifer R. Diamond, Matthew D. Hellmann, Benedito A. Carneiro

    Foilsithe / Cruthaithe 2024
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers

    Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers de réir Mingjia Li, Daniel Spakowicz, Jarred Burkart, Sandip Pravin Patel, Marium Husain, Kai He, Erin M. Bertino, Peter G. Shields, David P. Carbone, Claire F. Verschraegen, Carolyn J. Presley, Gregory A. Otterson, Kari Kendra, Dwight H. Owen

    Foilsithe / Cruthaithe 2019
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: